These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 19814588)
1. rhBMP2/7 heterodimer: an osteoblastogenesis inducer of not higher potency but lower effective concentration compared with rhBMP2 and rhBMP7 homodimers. Zheng Y; Wu G; Zhao J; Wang L; Sun P; Gu Z Tissue Eng Part A; 2010 Mar; 16(3):879-87. PubMed ID: 19814588 [TBL] [Abstract][Full Text] [Related]
2. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. Puleo DA J Cell Physiol; 1997 Oct; 173(1):93-101. PubMed ID: 9326453 [TBL] [Abstract][Full Text] [Related]
3. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446 [TBL] [Abstract][Full Text] [Related]
4. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. Luu HH; Song WX; Luo X; Manning D; Luo J; Deng ZL; Sharff KA; Montag AG; Haydon RC; He TC J Orthop Res; 2007 May; 25(5):665-77. PubMed ID: 17290432 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
6. Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro. Gruber R; Kandler B; Fischer MB; Watzek G Clin Oral Implants Res; 2006 Apr; 17(2):188-93. PubMed ID: 16584415 [TBL] [Abstract][Full Text] [Related]
7. [The biological effects of recombinant human bone morphogenetic protein 2 on human periodontal ligament fibroblasts]. Si X; Liu Z Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Feb; 20(1):10-3. PubMed ID: 12593191 [TBL] [Abstract][Full Text] [Related]
8. Porcine sinus mucosa holds cells that respond to bone morphogenetic protein (BMP)-6 and BMP-7 with increased osteogenic differentiation in vitro. Gruber R; Kandler B; Fuerst G; Fischer MB; Watzek G Clin Oral Implants Res; 2004 Oct; 15(5):575-80. PubMed ID: 15355400 [TBL] [Abstract][Full Text] [Related]
9. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin. Kodama T; Goto T; Miyazaki T; Takahashi T Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269 [TBL] [Abstract][Full Text] [Related]
10. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602 [TBL] [Abstract][Full Text] [Related]
11. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Aono A; Hazama M; Notoya K; Taketomi S; Yamasaki H; Tsukuda R; Sasaki S; Fujisawa Y Biochem Biophys Res Commun; 1995 May; 210(3):670-7. PubMed ID: 7763240 [TBL] [Abstract][Full Text] [Related]
12. [In vitro osteogenesis of the compound of chitosan and recombinant human bone morphogenetic protein 2]. Liang D; Zuo A; Wang B; Zhang J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Sep; 19(9):721-4. PubMed ID: 16206761 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. Fromigué O; Marie PJ; Lomri A J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905 [TBL] [Abstract][Full Text] [Related]
14. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation. Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Laflamme C; Curt S; Rouabhia M Arch Oral Biol; 2010 Sep; 55(9):689-701. PubMed ID: 20627196 [TBL] [Abstract][Full Text] [Related]
16. BMP2/7 heterodimer can modulate all cellular events of the in vitro RANKL-mediated osteoclastogenesis, respectively, in different dose patterns. Zheng Y; Wang L; Zhang X; Zhang X; Gu Z; Wu G Tissue Eng Part A; 2012 Mar; 18(5-6):621-30. PubMed ID: 21981321 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human bone morphogenetic protein (rhBMP)9 induces osteoblast differentiation when combined with demineralized freeze-dried bone allografts (DFDBAs) or biphasic calcium phosphate (BCP). Fujioka-Kobayashi M; Schaller B; Zhang Y; Kandalam U; Hernandez M; Miron RJ Clin Oral Investig; 2017 Jun; 21(5):1883-1893. PubMed ID: 27771827 [TBL] [Abstract][Full Text] [Related]
18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780 [TBL] [Abstract][Full Text] [Related]
19. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. Abe Y; Abe T; Aida Y; Hara Y; Maeda K J Bone Miner Res; 2004 Aug; 19(8):1302-7. PubMed ID: 15231018 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]